Cargando…

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope

A problem in the search for an efficient vaccine against dengue virus is the immunodominance of the fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of the E dimers coating mature viral particles. Anti-FLE antibodies are broadly cross-reactive but poorly...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouvinski, Alexander, Dejnirattisai, Wanwisa, Guardado-Calvo, Pablo, Vaney, Marie-Christine, Sharma, Arvind, Duquerroy, Stéphane, Supasa, Piyada, Wongwiwat, Wiyada, Haouz, Ahmed, Barba-Spaeth, Giovanna, Mongkolsapaya, Juthathip, Rey, Félix A., Screaton, Gavin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457521/
https://www.ncbi.nlm.nih.gov/pubmed/28534525
http://dx.doi.org/10.1038/ncomms15411
_version_ 1783241555688030208
author Rouvinski, Alexander
Dejnirattisai, Wanwisa
Guardado-Calvo, Pablo
Vaney, Marie-Christine
Sharma, Arvind
Duquerroy, Stéphane
Supasa, Piyada
Wongwiwat, Wiyada
Haouz, Ahmed
Barba-Spaeth, Giovanna
Mongkolsapaya, Juthathip
Rey, Félix A.
Screaton, Gavin R.
author_facet Rouvinski, Alexander
Dejnirattisai, Wanwisa
Guardado-Calvo, Pablo
Vaney, Marie-Christine
Sharma, Arvind
Duquerroy, Stéphane
Supasa, Piyada
Wongwiwat, Wiyada
Haouz, Ahmed
Barba-Spaeth, Giovanna
Mongkolsapaya, Juthathip
Rey, Félix A.
Screaton, Gavin R.
author_sort Rouvinski, Alexander
collection PubMed
description A problem in the search for an efficient vaccine against dengue virus is the immunodominance of the fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of the E dimers coating mature viral particles. Anti-FLE antibodies are broadly cross-reactive but poorly neutralizing, displaying a strong infection enhancing potential. FLE exposure takes place via dynamic ‘breathing' of E dimers at the virion surface. In contrast, antibodies targeting the E dimer epitope (EDE), readily exposed at the E dimer interface over the region of the conserved fusion loop, are very potent and broadly neutralizing. We here engineer E dimers locked by inter-subunit disulfide bonds, and show by X-ray crystallography and by binding to a panel of human antibodies that these engineered dimers do not expose the FLE, while retaining the EDE exposure. These locked dimers are strong immunogen candidates for a next-generation vaccine.
format Online
Article
Text
id pubmed-5457521
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54575212017-06-08 Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope Rouvinski, Alexander Dejnirattisai, Wanwisa Guardado-Calvo, Pablo Vaney, Marie-Christine Sharma, Arvind Duquerroy, Stéphane Supasa, Piyada Wongwiwat, Wiyada Haouz, Ahmed Barba-Spaeth, Giovanna Mongkolsapaya, Juthathip Rey, Félix A. Screaton, Gavin R. Nat Commun Article A problem in the search for an efficient vaccine against dengue virus is the immunodominance of the fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of the E dimers coating mature viral particles. Anti-FLE antibodies are broadly cross-reactive but poorly neutralizing, displaying a strong infection enhancing potential. FLE exposure takes place via dynamic ‘breathing' of E dimers at the virion surface. In contrast, antibodies targeting the E dimer epitope (EDE), readily exposed at the E dimer interface over the region of the conserved fusion loop, are very potent and broadly neutralizing. We here engineer E dimers locked by inter-subunit disulfide bonds, and show by X-ray crystallography and by binding to a panel of human antibodies that these engineered dimers do not expose the FLE, while retaining the EDE exposure. These locked dimers are strong immunogen candidates for a next-generation vaccine. Nature Publishing Group 2017-05-23 /pmc/articles/PMC5457521/ /pubmed/28534525 http://dx.doi.org/10.1038/ncomms15411 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Rouvinski, Alexander
Dejnirattisai, Wanwisa
Guardado-Calvo, Pablo
Vaney, Marie-Christine
Sharma, Arvind
Duquerroy, Stéphane
Supasa, Piyada
Wongwiwat, Wiyada
Haouz, Ahmed
Barba-Spaeth, Giovanna
Mongkolsapaya, Juthathip
Rey, Félix A.
Screaton, Gavin R.
Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title_full Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title_fullStr Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title_full_unstemmed Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title_short Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
title_sort covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457521/
https://www.ncbi.nlm.nih.gov/pubmed/28534525
http://dx.doi.org/10.1038/ncomms15411
work_keys_str_mv AT rouvinskialexander covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT dejnirattisaiwanwisa covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT guardadocalvopablo covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT vaneymariechristine covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT sharmaarvind covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT duquerroystephane covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT supasapiyada covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT wongwiwatwiyada covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT haouzahmed covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT barbaspaethgiovanna covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT mongkolsapayajuthathip covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT reyfelixa covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope
AT screatongavinr covalentlylinkeddenguevirusenvelopeglycoproteindimersreduceexposureoftheimmunodominantfusionloopepitope